SELLAS Life Sciences SLS
NASDAQ SLS
$11.74 +0.41 (+3.62%)
At close: Oct 2, 2026 · 4:00 PM EDT

SELLAS Life Sciences (SLS) Return on Capital Employed [ROCE] (2012 - 2026)

Updated

SELLAS Life Sciences (SLS) posted Return on Capital Employed [ROCE] of -28.82% for Q2 2026, up 69.56 percentage points from -98.38% a year earlier and up 6.22 percentage points from the prior quarter.

Analysis

SELLAS Life Sciences (SLS) Return on Capital Employed [ROCE] (2012 - 2026) Analysis & Trends

For FY2025, SELLAS Life Sciences' Return on Capital Employed [ROCE] came in at -67.53%, up 882.95 percentage points from FY2024.

  • Annual Return on Capital Employed [ROCE] shows a five-year change of +21.89 percentage points (FY2020 to FY2025).
  • In prior years, SELLAS Life Sciences' Return on Capital Employed [ROCE] was -950.48% in FY2024, -518.29% in FY2022 (-437.16 pp) and -81.12% in FY2021 (+8.29 pp).
  • The Q2 2026 figure stands as the highest quarterly Return on Capital Employed [ROCE] since Q3 2017.
  • On a year-over-year basis, Return on Capital Employed [ROCE] has increased in each of the last six quarters, with an average year-over-year change of +1004.32 percentage points over the last seven quarters.
  • The strongest year-over-year quarter for Return on Capital Employed [ROCE] in the past five years was Q1 2025, with a gain of 3935.86 percentage points; the weakest was Q1 2024, with a drop of 3689.75 percentage points.
  • According to Business Quant data, Return on Capital Employed [ROCE] for the three prior quarters was -35.03% (Q1 2026), -48.80% (Q4 2025) and -74.81% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 17.83%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 17.92%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 6.28%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 19.32%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.54%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 16.66%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -5.97%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.86%
10 SELLAS Life Sciences 2.37 Bn 2.37 Bn - -28.82%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -28.82%
Mar 31, 2026 -35.03%
Dec 31, 2025 -48.80%
Sep 30, 2025 -74.81%
Jun 30, 2025 -98.38%
Mar 31, 2025 -137.55%
Dec 31, 2024 -234.15%
Sep 30, 2024 -321.33%
Jun 30, 2024 -450.16%
Mar 31, 2024 -4,073.41%
Sep 30, 2023 -2,459.96%
Jun 30, 2023 -354.55%
Mar 31, 2023 -383.66%
Dec 31, 2022 -527.21%
Sep 30, 2022 -266.56%
Jun 30, 2022 -300.31%
Mar 31, 2022 -301.95%
Dec 31, 2021 -93.23%
Sep 30, 2021 -50.28%
Jun 30, 2021 -40.54%
API Access

SELLAS Life Sciences Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=SLS&period=max&api_key=YOUR_API_KEY